EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)StudienprotokollOpen Access

Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer

Ambrosia Simmons, David Sher, Dr Dong Wook Nathan Kim, Marilyn Leitch, Rachel Wooldridge, Sally Goudreau, Stephen Seiler, Sarah Neufeld, Maggie Stein, Kevin Albuquerque, Ann Spangler, John Heinzerling und 6 weitere

Practical Radiation Oncology · 2025

DOI: 10.1016/j.prro.2024.08.012 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Practical Radiation Oncology, 2025. Verfasst von Ambrosia Simmons und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University Texas Southwestern Medical Center, Dallas. Hauptthemen laut MEDLINE: Breast Neoplasms, Quality of Life, Radiosurgery. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: We report the financial toxicity and quality-of-life outcomes of our prospective phase 1 dose-escalation study of 5-fraction stereotactic partial breast irradiation (S-PBI) for early-stage breast cancer. MATERIALS AND METHODS: Women with unifocal in situ or invasive epithelial histologies, clinical stages 0, I, or II with tumor size < 3 cm treated with lumpectomy were enrolled in our phase 1 5-fraction S-PBI dose-escalation trial. Our institutionally generated questionnaire on the "Patient Perspective Cost and Convenience of Care" and the EuroQol 5-Dimension 5-level questionnaire were administered to patients treated at follow-up. RESULTS: Between 2010 and 2015, 68 of the 75 patients who enrolled and completed treatment on trial completed at least some component of either the EuroQol 5-Dimension 5-level questionnaire or the "Patient Perspective Cost and Convenience of Care" questionnaire. Nearly all patients reported very high satisfaction with their treatment overall, particularly the shortened length of treatment. Over half of the patients reported some level of financial toxicity (FT) despite a significantly shortened treatment time. Patients who reported any FT were significantly younger than patients with no financial burden of treatment (means 59.2 and 63.7, respectively, P = .03). There was no difference in those who reported any level of FT based on patient race, ethnicity, marital, or employment status. This S-PBI regimen did not significantly affect quality of life over a 4-year follow-up. CONCLUSIONS: These patient-reported outcomes suggest that the use of accelerated partial breast irradiation may offer low FT rates in breast cancer care, particularly for disadvantaged patient groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsQuality of LifeRadiosurgeryHumansFemaleMiddle AgedAgedProspective StudiesAdultSurveys and QuestionnairesAged, 80 and overNeoplasm Staging

Autor:innen und Institutionen

  • Department of Radiation Oncology, University Texas Southwestern Medical Center, Dallas.
  • Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Department of Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Department of Radiation Oncology, Atrium Health, Levine Cancer Center, Concord, North Carolina.
  • Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Department of Radiation Oncology, University Texas Southwestern Medical Center, Dallas. Electronic address: Asal.Rahimi@UTSouthwestern.edu.

Förderung

  • NCI NIH HHS

Zitieren

APA

Simmons, A., Sher, D., Kim, D. D. W. N., Leitch, M., Wooldridge, R., Goudreau, S., Seiler, S., Neufeld, S., Stein, M., Albuquerque, K., Spangler, A., Heinzerling, J., Garwood, D., Stevenson, S., Ahn, C., Ding, C., Timmerman, R. D., & Rahimi, A. (2025). Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer. Practical Radiation Oncology. https://doi.org/10.1016/j.prro.2024.08.012

Vancouver

Simmons A, Sher D, Kim DDWN, Leitch M, Wooldridge R, Goudreau S, et al. Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer. Practical Radiation Oncology. 2025. doi:10.1016/j.prro.2024.08.012

BibTeX
@article{Simmons2025,
  author = {Simmons, Ambrosia and Sher, David and Kim, Dr Dong Wook Nathan and Leitch, Marilyn and Wooldridge, Rachel and Goudreau, Sally and Seiler, Stephen and Neufeld, Sarah and Stein, Maggie and Albuquerque, Kevin and Spangler, Ann and Heinzerling, John and Garwood, Dan and Stevenson, Stella and Ahn, Chul and Ding, Chuxiong and Timmerman, Robert D and Rahimi, Asal},
  title = {Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer},
  journal = {Practical Radiation Oncology},
  year = {2025},
  doi = {10.1016/j.prro.2024.08.012}
}
Kostenlos starten →